HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 radioembolization mapping for ...
Modern medical research shows that drug and surgical treatments for benign prostatic hyperplasia and chronic prostatitis carry high risks, while Dr Allen's Device, developed by Fine Treatment, an ...
The MarketWatch News Department was not involved in the creation of this content. Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen's Devices are designed to treat different chronic ...
If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results